GE HealthCare Stock Is Rising on Strong Earnings and Outlook
Wuensch rates GE HealthCare stock at Buy with a $103 price target. Coming into Thursday, GE HealthCare stock has risen about ...
GE HealthCare price target raised to $110 from $103 at Citi
Citi raised the firm’s price target on GE HealthCare (GEHC) to $110 from $103 and keeps a Buy rating on the shares. Operating margins expanded ...
Opinion
BizTimes3hOpinion
Viewpoints: NIH-funded research produces cures, treatments and jobs, even if it takes time
Howard Temin was a UW-Madison scientist who shared the 1975 Nobel Prize for his discovery of “reverse transcriptase,” which described how tumor viruses ...
Why Is GE HealthCare Stock Trading Soaring On Thursday?
GE HealthCare Q4 earnings beat estimates with strong U.S. demand. 2025 outlook includes 2%-3% revenue growth and EPS guidance of $4.61-$4.75.
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Modern Healthcare4h
GE HealthCare doubles down on AI with new devices, acquisitions
During the company's fourth-quarter earnings call Thursday, Arduini said the company has no plans to slow down. During the ...
Southeast Missourian4h
Fat profit reports lift Wall Street ahead of a tariff announcement
U.S. stocks climb as strong profit reports from major companies, including MGM Resorts and GE HealthCare, boost Wall Street.
GE HealthCare projects $4.61-$4.75 adjusted EPS for 2025 amid margin expansion and Flyrcado launch
Discover GE HealthCare's Q4 2024 insights: record $19.8B backlog, 18.7% margin growth, and Flyrcado's 2025 launch.